查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1493293

干细胞治疗市场规模、份额、趋势分析报告：依治疗类型、治疗应用、地区、细分市场预测，2024-2030

Stem Cell Therapy Market Size, Share & Trends Analysis Report By Therapy Type, By Therapeutic Application (Oncology, Cardiovascular Disease, Musculoskeletal Disorders), By Region, And Segment Forecasts, 2024 - 2030
出版日期: | 出版商: Grand View Research | 英文 100 Pages | 商品交期: 2-10个工作天内

价格

干细胞治疗市场成长与趋势：

根据Grand View Research, Inc.最新报告，预计到2030年，全球干细胞治疗市场规模将达到16.701亿美元，预计2024年至2030年复合年增长率为24.15%。

干细胞研究和技术的进步彻底改变了再生医学领域。干细胞分离、表征和操作技术的突破性进展使研究人员能够更准确、更有效地利用干细胞的治疗潜力。例如，2023年5月，EPROCELL推出了合约开发和受託製造厂商（CDMO）服务，以製造源自间质干细胞（MSC）的先进治疗药品（ATMP）。与 Histocell 的合作促进了这一扩张。这些进步正在推动从慢性疾病到退化性疾病等多种疾病的创新治疗方法的开发。

慢性病和退化性疾病的日益普及刺激了对新治疗方法的需求。心血管疾病、神经退化性疾病、整形外科损伤和自体免疫疾病等疾病对医疗保健提出了重大挑战，并推动了对创新治疗方法的探索。例如，《柳叶刀神经病学》杂誌上发表的一项研究预测，到 2040 年，受帕金森氏症影响的人数将大幅增加。这些预测数字令人震惊，因为它们表明全球受这种神经退化性疾病影响的人数可能会翻一番，达到至少 1,290 万人。干细胞疗法在解决这些复杂疾病方面具有广阔的前景，包括促进组织再生、调节免疫反应和恢復器官功能，为疾病管理和治疗提供新途径。

随着投资者认识到突破性的医疗进步和丰厚回报的潜力，全球市场的投资正在稳步增加。资本的涌入推动了研究、开发和商业化工作，推动了整体市场的成长。随着对再生医学和个人化医疗保健的日益重视，市场有望继续扩大，并为与各种医疗状况作斗争的患者提供创新的治疗方法和新的希望。

干细胞治疗市场报告亮点

  • 按治疗类型划分，到2023年，异体干细胞治疗领域将以68.41%的收益占有率引领市场，预计在预测期内将以26.74%的复合年增长率增长最快。
  • 从治疗应用来看，在持续研究和临床进展的推动下，包括血液疾病和神经系统疾病在内的其他治疗领域将在 2023 年以 72.75% 的最大销售份额引领市场。
  • 北美以 2023 年最高收益占有率50.11% 占据市场主导地位，由于几个关键因素，预计在预测期内将以 28.07% 的最快复合年增长率增长。市场成长是由有利的法律规范、慢性病发病率上升和技术进步所推动的。

目录

第一章调查方法与范围

第 2 章执行摘要

第三章 市场变数、趋势与范围

  • 市场体系展望
    • 母市场展望
    • 相关/辅助市场展望
  • 市场动态
    • 市场驱动因素分析
    • 市场限制因素分析
  • 产业分析工具
    • 波特五力分析
    • PESTEL分析
    • COVID-19 影响分析

第四章干细胞治疗市场：依治疗类型的业务分析

  • 细分仪表板
  • 全球干细胞治疗市场治疗类型波动分析
  • 2018-2030年全球干细胞治疗市场规模与趋势分析（依治疗类型）
  • 同种异体干细胞疗法
  • 自体干细胞治疗

第五章干细胞治疗市场：治疗应用的商业分析

  • 细分仪表板
  • 全球干细胞治疗市场的治疗应用与波动分析
  • 2018-2030年全球干细胞治疗市场规模与趋势分析（依治疗应用）
  • 肿瘤学
  • 心血管疾病（CVD）
  • 肌肉骨骼疾病
  • 其他的

第六章干细胞治疗市场：依治疗类型和治疗应用进行区域估计和趋势分析

  • 区域仪表板
  • 2018-2030年市场规模及预测及趋势分析
  • 北美洲
  • 欧洲
  • 亚太地区
  • 世界其他地区

第七章 竞争格局

  • 参与企业
  • 策略规划
  • 2023 年企业市场分析
  • 参与企业概况
    • Bluebird Bio, Inc.
    • NIPRO
    • Orchard Therapeutics plc
    • Pharmicell Co., Ltd.
    • CorestemChemon Inc.
    • ANTEROGEN.CO.,LTD.
    • Holostem Srl
    • Vertex Pharmaceuticals, Inc.
    • Cleveland Cord Blood Center
    • Gamida Cell Ltd.
Product Code: GVR-4-68040-274-4

Stem Cell Therapy Market Growth & Trends:

The global stem cell therapy market size is anticipated to reach USD 1,670.1 million by 2030 and is projected to grow at a CAGR of 24.15% from 2024 to 2030, according to a new report by Grand View Research, Inc. The market growth is propelled by several key factors that underscore both scientific advancements and evolving healthcare needs.Advancements in stem cell research and technology have revolutionized the landscape of regenerative medicine. Breakthroughs in stem cell isolation, characterization, and manipulation techniques have empowered researchers to harness the therapeutic potential of stem cells with greater precision and efficacy. For instance, in May 2023, EPROCELL introduced Contract Development and Manufacturing Organization (CDMO) services for producing Advanced Therapies Medicinal Products (ATMPs) derived from mesenchymal stem cells (MSC). This expansion is facilitated by a partnership with Histocell. These advancements have spurred the development of innovative therapies targeting a wide spectrum of medical conditions, from chronic diseases to degenerative disorders.

The increasing prevalence of chronic and degenerative diseases has fueled the demand for novel treatment modalities. Conditions such as cardiovascular diseases, neurodegenerative disorders, orthopedic injuries, and autoimmune diseases pose significant healthcare challenges, driving the search for innovative therapeutic approaches. For instance, a study published in The Lancet Neurology has anticipated a significant increase in the number of individuals affected by Parkinson's disease by the year 2040. The projected figure is alarming, as it suggests that the number of people living with this neurodegenerative disorder may double, reaching at least 12.9 million worldwide. Stem cell therapies hold immense promise in addressing these complex diseases by promoting tissue regeneration, modulating immune responses, and restoring organ function, thus offering new avenues for disease management and treatment.

Investment in the global market has been steadily increasing as investors recognize the potential for groundbreaking medical advancements and lucrative returns. This influx of capital fuels research, development, and commercialization efforts, driving the overall market growth. With a growing emphasis on regenerative medicine and personalized healthcare, the market is poised for continued expansion, offering innovative treatments and renewed hope to patients grappling with a wide range of medical conditions.

Stem Cell Therapy Market Report Highlights:

  • Based on therapy type, the allogeneic stem cell therapies segment led the market with the largest revenue share of 68.41% by 2023 and is anticipated to grow at the fastest CAGR of 26.74% during the forecast period, propelled by a convergence of factors contributing to its expansion such as increasing landscape of research and clinical trials within the field
  • Based on therapeutic application, the other therapeutic segment including diseases such as blood disorders, and neurological disorders led the market with the largest revenue share of 72.75% in 2023, fueled by ongoing research and clinical advancements
  • North America dominated the market with the largest revenue share of 50.11% in 2023 and is anticipated to grow at the fastest CAGR of 28.07% during the forecast period, driven by several key factors. The market growth is facilitated by favorable regulatory frameworks, rising rates of chronic diseases, and technological improvements

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Market Definitions
    • 1.2.1. Therapy Type
    • 1.2.2. Therapeutic Application
  • 1.3. Information analysis
  • 1.4. Market formulation & data visualization
  • 1.5. Data validation & publishing
  • 1.6. Information Procurement
    • 1.6.1. Primary Research
  • 1.7. Information or Data Analysis
  • 1.8. Market Formulation & Validation
  • 1.9. Market Model
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/Ancillary Market Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
      • 3.2.1.1. Growing research & development in stem cell therapy
      • 3.2.1.2. Increasing prevalence of chronic diseases
      • 3.2.1.3. Technological advancements
    • 3.2.2. Market Restraint Analysis
      • 3.2.2.1. High cost of stem cell therapy
  • 3.3. Industry Analysis Tools
    • 3.3.1. Porter's Five Forces Analysis
    • 3.3.2. PESTEL Analysis
    • 3.3.3. COVID-19 Impact Analysis

Chapter 4. Stem Cell Therapy Market: Therapy Type Business Analysis

  • 4.1. Segment Dashboard
  • 4.2. Global Stem Cell Therapy Market Therapy Type Movement Analysis
  • 4.3. Global Stem Cell Therapy Market Size & Trend Analysis, by Therapy Type, 2018 to 2030 (USD Million)
  • 4.4. Allogeneic Stem Cell Therapies
    • 4.4.1. Global Allogeneic Stem Cell Therapies Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.4.2. Hematopoietic Stem Cell Therapies
      • 4.4.2.1. Global Hematopoietic Stem Cell Therapies Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.4.3. Mesenchymal Stem Cell Therapies
      • 4.4.3.1. Global Mesenchymal Stem Cell Therapies Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.5. Autologous Stem Cell Therapies, by Type
    • 4.5.1. Global Autologous Stem Cell Therapies, by Type Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.5.2. BM, Blood, & Umbilical Cord-derived Stem Cells
      • 4.5.2.1. Global BM, Blood, & Umbilical Cord-derived Stem Cells Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.5.3. Adipose-Derived Cells
      • 4.5.3.1. Global Adipose-Derived Cells Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.5.4. Others
      • 4.5.4.1. Global Others Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. Stem Cell Therapy Market: Therapeutic Application Business Analysis

  • 5.1. Segment Dashboard
  • 5.2. Global Stem Cell Therapy Market Therapeutic Application, Movement Analysis
  • 5.3. Global Stem Cell Therapy Market Size & Trend Analysis, by Therapeutic Application, 2018 to 2030 (USD Million)
  • 5.4. Oncology
    • 5.4.1. Global Oncology Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.5. Cardiovascular Disease (CVD)
    • 5.5.1. Global Cardiovascular Disease (CVD) Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.6. Musculoskeletal Disorders
    • 5.6.1. Global Musculoskeletal Disorders Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.7. Others
    • 5.7.1. Global Others Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. Stem Cell Therapy Market: Regional Estimates & Trend Analysis by Therapy Type, and Therapeutic Application

  • 6.1. Regional Dashboard
  • 6.2. Market Size & Forecasts and Trend Analysis, 2018 to 2030
  • 6.3. North America
    • 6.3.1. North America Stem Cell Therapy Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.2. U.S.
      • 6.3.2.1. Key Country Dynamics
      • 6.3.2.2. Competitive Scenario
      • 6.3.2.3. Regulatory Framework
      • 6.3.2.4. U.S. Stem Cell Therapy Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.3. Canada
      • 6.3.3.1. Key Country Dynamics
      • 6.3.3.2. Competitive Scenario
      • 6.3.3.3. Regulatory Framework
      • 6.3.3.4. Canada Stem Cell Therapy Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.4. Europe
    • 6.4.1. Europe Stem Cell Therapy Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.4.2. UK
      • 6.4.2.1. Key Country Dynamics
      • 6.4.2.2. Competitive Scenario
      • 6.4.2.3. Regulatory Framework
      • 6.4.2.4. UK Stem Cell Therapy Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.4.3. Germany
      • 6.4.3.1. Key Country Dynamics
      • 6.4.3.2. Competitive Scenario
      • 6.4.3.3. Regulatory Framework
      • 6.4.3.4. Germany Stem Cell Therapy Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.4.4. Switzerland
      • 6.4.4.1. Key Country Dynamics
      • 6.4.4.2. Competitive Scenario
      • 6.4.4.3. Regulatory Framework
      • 6.4.4.4. Switzerland Stem Cell Therapy Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5. Asia Pacific
    • 6.5.1. Asia Pacific Stem Cell Therapy Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.5.2. Japan
      • 6.5.2.1. Key Country Dynamics
      • 6.5.2.2. Competitive Scenario
      • 6.5.2.3. Regulatory Framework
      • 6.5.2.4. Japan Stem Cell Therapy Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.5.3. China
      • 6.5.3.1. Key Country Dynamics
      • 6.5.3.2. Competitive Scenario
      • 6.5.3.3. Regulatory Framework
      • 6.5.3.4. China Stem Cell Therapy Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.5.4. India
      • 6.5.4.1. Key Country Dynamics
      • 6.5.4.2. Competitive Scenario
      • 6.5.4.3. Regulatory Framework
      • 6.5.4.4. India Stem Cell Therapy Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.5.5. South Korea
      • 6.5.5.1. Key Country Dynamics
      • 6.5.5.2. Competitive Scenario
      • 6.5.5.3. Regulatory Framework
      • 6.5.5.4. South Korea Stem Cell Therapy Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.6. Rest of World
    • 6.6.1. Rest of World Stem Cell Therapy Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. Competitive Landscape

  • 7.1. Participant Categorization
  • 7.2. Strategy Mapping
  • 7.3. Company Market Position Analysis, 2023
  • 7.4. Participant's Overview
    • 7.4.1. Bluebird Bio, Inc.
      • 7.4.1.1. Overview
      • 7.4.1.2. Financial Performance
      • 7.4.1.3. Product Benchmarking
      • 7.4.1.4. Strategic Initiatives
    • 7.4.2. NIPRO
      • 7.4.2.1. Overview
      • 7.4.2.2. Financial Performance
      • 7.4.2.3. Product Benchmarking
      • 7.4.2.4. Strategic Initiatives
    • 7.4.3. Orchard Therapeutics plc
      • 7.4.3.1. Overview
      • 7.4.3.2. Financial Performance
      • 7.4.3.3. Product Benchmarking
      • 7.4.3.4. Strategic Initiatives
    • 7.4.4. Pharmicell Co., Ltd.
      • 7.4.4.1. Overview
      • 7.4.4.2. Financial Performance
      • 7.4.4.3. Product Benchmarking
      • 7.4.4.4. Strategic Initiatives
    • 7.4.5. CorestemChemon Inc.
      • 7.4.5.1. Overview
      • 7.4.5.2. Financial Performance
      • 7.4.5.3. Product Benchmarking
      • 7.4.5.4. Strategic Initiatives
    • 7.4.6. ANTEROGEN.CO.,LTD.
      • 7.4.6.1. Overview
      • 7.4.6.2. Financial Performance
      • 7.4.6.3. Product Benchmarking
      • 7.4.6.4. Strategic Initiatives
    • 7.4.7. Holostem S.r.l.
      • 7.4.7.1. Overview
      • 7.4.7.2. Financial Performance
      • 7.4.7.3. Product Benchmarking
      • 7.4.7.4. Strategic Initiatives
    • 7.4.8. Vertex Pharmaceuticals, Inc.
      • 7.4.8.1. Overview
      • 7.4.8.2. Financial Performance
      • 7.4.8.3. Product Benchmarking
      • 7.4.8.4. Strategic Initiatives
    • 7.4.9. Cleveland Cord Blood Center
      • 7.4.9.1. Overview
      • 7.4.9.2. Financial Performance
      • 7.4.9.3. Product Benchmarking
      • 7.4.9.4. Strategic Initiatives
    • 7.4.10. Gamida Cell Ltd.
      • 7.4.10.1. Overview
      • 7.4.10.2. Financial Performance
      • 7.4.10.3. Product Benchmarking
      • 7.4.10.4. Strategic Initiatives

List of Tables

  • Table 1 List of secondary sources
  • Table 2 List of abbreviations
  • Table 3 Global stem cell therapy market, by therapy type, 2018 - 2030 (USD Million)
  • Table 4 Global stem cell therapy market, by application, 2018 - 2030 (USD Million)
  • Table 5 Global stem cell therapy market, by region, 2018 - 2030 (USD Million)
  • Table 6 North America stem cell therapy market, by country, 2018 - 2030 (USD Million)
  • Table 7 North America stem cell therapy market, by therapy type, 2018 - 2030 (USD Million)
  • Table 8 North America stem cell therapy market, by therapeutical application, 2018 - 2030 (USD Million)
  • Table 9 U.S. stem cell therapy market, by therapy type, 2018 - 2030 (USD Million)
  • Table 10 U.S. stem cell therapy market, by therapeutical application, 2018 - 2030 (USD Million)
  • Table 11 U.S. stem cell therapy market, by end-use, 2018 - 2030 (USD Million)
  • Table 12 Canada stem cell therapy market, by therapy type, 2018 - 2030 (USD Million)
  • Table 13 Canada stem cell therapy market, by therapeutical application, 2018 - 2030 (USD Million)
  • Table 14 Europe stem cell therapy market, by country, 2018 - 2030 (USD Million)
  • Table 15 Europe stem cell therapy market, by therapy type, 2018 - 2030 (USD Million)
  • Table 16 Europe stem cell therapy market, by therapeutical application, 2018 - 2030 (USD Million)
  • Table 17 UK stem cell therapy market, by therapy type, 2018 - 2030 (USD Million)
  • Table 18 UK stem cell therapy market, by therapeutical application, 2018 - 2030 (USD Million)
  • Table 19 Germany stem cell therapy market, by therapy type, 2018 - 2030 (USD Million)
  • Table 20 Germany stem cell therapy market, by therapeutical application, 2018 - 2030 (USD Million)
  • Table 21 Switzerland stem cell therapy market, by therapy type, 2018 - 2030 (USD Million)
  • Table 22 Switzerland stem cell therapy market, by therapeutical application, 2018 - 2030 (USD Million)
  • Table 23 Asia Pacific stem cell therapy market, by country, 2018 - 2030 (USD Million)
  • Table 24 Asia Pacific stem cell therapy market, by therapy type, 2018 - 2030 (USD Million)
  • Table 25 Asia Pacific stem cell therapy market, by therapeutical application, 2018 - 2030 (USD Million)
  • Table 26 Japan stem cell therapy market, by therapy type, 2018 - 2030 (USD Million)
  • Table 27 Japan stem cell therapy market, by therapeutical application, 2018 - 2030 (USD Million)
  • Table 28 China stem cell therapy market, by therapy type, 2018 - 2030 (USD Million)
  • Table 29 China stem cell therapy market, by therapeutical application, 2018 - 2030 (USD Million)
  • Table 30 India stem cell therapy market, by therapy type, 2018 - 2030 (USD Million)
  • Table 31 India stem cell therapy market, by therapeutical application, 2018 - 2030 (USD Million)
  • Table 32 South Korea stem cell therapy market, by therapy type, 2018 - 2030 (USD Million)
  • Table 33 South Korea stem cell therapy market, by therapeutical application, 2018 - 2030 (USD Million)
  • Table 34 Rest of World stem cell therapy market, by therapy type, 2018 - 2030 (USD Million)
  • Table 35 Rest of World stem cell therapy market, by therapeutical application, 2018 - 2030 (USD Million)
  • Table 36 Participant's overview
  • Table 37 Financial performance
  • Table 38 Key companies undergoing expansions
  • Table 39 Key companies undergoing acquisitions
  • Table 40 Key companies undergoing collaborations
  • Table 41 Key companies launching new products
  • Table 42 Key companies undertaking other strategies

List of Figures

  • Fig. 1 Stem cell therapy market segmentation
  • Fig. 2 Market research process
  • Fig. 3 Data triangulation techniques
  • Fig. 4 Primary research pattern
  • Fig. 5 Market research approaches
  • Fig. 6 Market formulation & validation
  • Fig. 7 Market outlook
  • Fig. 8 Segment snapshot
  • Fig. 9 Competitive landscape snapshot
  • Fig. 10 Parent market outlook
  • Fig. 11 Stem cell therapy market driver analysis
  • Fig. 12 Stem cell therapy market restraint analysis
  • Fig. 13 Stem cell therapy market: Porter's analysis
  • Fig. 14 Stem cell therapy market: PESTEL analysis
  • Fig. 15 Stem cell therapy market: Therapy type outlook and key takeaways
  • Fig. 16 Stem cell therapy market: Therapy type market share analysis, 2023 - 2030
  • Fig. 17 Global stem cell therapy by allogeneic stem cell therapies market, 2018 - 2030 (USD Million)
  • Fig. 18 Global stem cell therapy by hematopoietic stem cell therapies market, 2018 - 2030 (USD Million)
  • Fig. 19 Global stem cell therapy by mesenchymal stem cell therapies market, 2018 - 2030 (USD Million)
  • Fig. 20 Global stem cell therapy by autologous stem cell therapies market, 2018 - 2030 (USD Million)
  • Fig. 21 Global stem cell therapy by BM, blood, & umbilical cord-derived stem cells market, 2018 - 2030 (USD Million)
  • Fig. 22 Global stem cell therapy by adipose derived cells market, 2018 - 2030 (USD Million)
  • Fig. 23 Global stem cell therapy by others market, 2018 - 2030 (USD Million)
  • Fig. 24 Stem cell therapy market: Therapeutical application outlook and key takeaways
  • Fig. 25 Stem cell therapy market: Therapeutical application market share analysis, 2023-2030
  • Fig. 26 Global stem cell therapy by oncology market, 2018 - 2030 (USD Million)
  • Fig. 27 Global stem cell therapy by cardiovascular disease (CVD) market, 2018 - 2030 (USD Million)
  • Fig. 28 Global stem cell therapy by musculoskeletal disorders market, 2018 - 2030 (USD Million)
  • Fig. 29 Global stem cell therapy by other market, 2018 - 2030 (USD Million)
  • Fig. 30 Regional marketplace: Key takeaways
  • Fig. 31 North America stem cell therapy market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 32 U.S. stem cell therapy market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 33 Canada stem cell therapy market, 2018 - 2030 (USD Million)
  • Fig. 34 Europe stem cell therapy market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 35 UK stem cell therapy market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 36 Germany stem cell therapy market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 37 Switzerland stem cell therapy market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 38 Asia-Pacific stem cell therapy market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 39 Japan stem cell therapy market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 40 China stem cell therapy market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 41 India stem cell therapy market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 42 South Korea stem cell therapy market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 43 Rest of World stem cell therapy market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 44 Key company categorization
  • Fig. 45 Company market positioning
  • Fig. 46 Market participant categorization
  • Fig. 47 Strategy framework